Double-Duty drugs: new hope for slowing deadly lung disease?
NCT ID NCT03939520
Summary
This study looked for a better way to treat people with a serious, progressive lung scarring disease (idiopathic pulmonary fibrosis or IPF) when their current single drug stops working well. Researchers tested if combining the two approved drugs (pirfenidone and nintedanib) was more effective and safe than simply switching to the other single drug. The trial involved 279 adults whose lung function was declining despite already being on one of the standard medications.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROGRESSIVE IDIOPATHIC PULMONARY FIBROSIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
AP - HP - Hôpital Avicenne
Bobigny, France
-
APHP - Hôpital Xavier Bichat-Claude Bernard
Paris, France
-
CHRU Hôpital Cavale Blanche
Brest, France
-
CHRU de Besançon - Hôpital Jean Minjoz
Besançon, France
-
CHRU de Lille - Hôpital Albert Calmette
Lille, France
-
CHRU de Montpellier - Hôpital Arnaud de Villeneuve
Montpellier, France
-
CHRU, Tours - Hôpital Bretonneau
Tours, France
-
CHU - Hôpital G.R. Laennec
Nantes, France
-
CHU Dijon Bourgogne - Hôpital François Mitterrand
Dijon, France
-
CHU Nancy - Hôpital Brabois
Vandœuvre-lès-Nancy, France
-
CHU Poitiers
Poitiers, 86021, France
-
CHU Rennes - Hôpital Pontchaillou
Rennes, France
-
CHU d'Angers
Angers, France
-
CHU de Caen - Hôpital de la Côte de Nacre
Caen, France
-
CHU de Marseille - Hôpital Nord
Marseille, France
-
CHU de Nice, Hôpital Pasteur
Nice, France
-
CHU de Toulouse - Hôpital Larrey
Toulouse, France
-
Centre Hospitalier de la côte Basque
Bayonne, France
-
Ch de Cornouaille
Quimper, France
-
Groupe Hospitalier Paris Saint Joseph
Paris, France
-
Hôpital Pneumologique et Cardiovasculaire Louis Pradel
Bron, France
-
Hôpital Robert Schuman
Vantoux, France
Conditions
Explore the condition pages connected to this study.